Skip to content

Clinical trials

Completed Lung Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20093
20121
20131
20142
20152
20164
20181
20193
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Bayer2
Respira Therapeutics, Inc.2
Vertex Pharmaceuticals Incorporated2
Bayside Health1
Checkpoint Therapeutics, Inc.1
Mercy Hospital for Women, Australia1
Novartis Pharmaceuticals1
OncoMed Pharmaceuticals, Inc.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases21
Respiratory Tract Diseases13
Cystic Fibrosis6
Lung Diseases, Obstructive5
Pulmonary Disease, Chronic Obstructive5
Asthma4
Bronchial Diseases4
Cardiovascular Diseases4
Genetic Diseases, Inborn4
Pancreatic Diseases4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.